Cargando…
Genetics, epigenetics and redox homeostasis in rhabdomyosarcoma: Emerging targets and therapeutics
Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma accounting for 5–8% of malignant tumours in children and adolescents. Children with high risk disease have poor prognosis. Anti-RMS therapies include surgery, radiation and combination chemotherapy. While these strategies improved surviva...
Autores principales: | Pal, Ananya, Chiu, Hsin Yao, Taneja, Reshma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6859585/ https://www.ncbi.nlm.nih.gov/pubmed/30709791 http://dx.doi.org/10.1016/j.redox.2019.101124 |
Ejemplares similares
-
EHMT2 epigenetically suppresses Wnt signaling and is a potential target in embryonal rhabdomyosarcoma
por: Pal, Ananya, et al.
Publicado: (2020) -
Mitochondrial calcium uptake regulates tumour progression in embryonal rhabdomyosarcoma
por: Chiu, Hsin Yao, et al.
Publicado: (2022) -
Targeting redox homeostasis in rhabdomyosarcoma cells: GSH-depleting agents enhance auranofin-induced cell death
por: Habermann, Karoline Johanna, et al.
Publicado: (2017) -
Exercise, redox homeostasis and the epigenetic landscape
por: Dimauro, Ivan, et al.
Publicado: (2020) -
Therapeutic Targeting of Cancer: Epigenetic Homeostasis
por: Yu, Xiaoyuan, et al.
Publicado: (2021)